SCHEMBL7522153

SCHEMBL7522153

NC(=O)c1cccnc1C(=O)N1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
POLB P06746 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PARP1 P09874 2/20 0.44
SPR P35270 1/20 0.44
HPGD P15428 4/20 0.44
ALDH1A1 P00352 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 1/20 0.43
CYP2C9 P11712 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 2/20 0.42
RECQL P46063 1/20 0.42
DHODH Q02127 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7455823 0.98 PARP1 (0.45) NPC1POLBMEN1KMT2AL3MBTL1
SCHEMBL7452728 0.95 PARP1 (0.45) NPC1POLBMEN1KMT2AL3MBTL1
SCHEMBL11204339 0.89 HTT (0.50) POLBMEN1KMT2AL3MBTL1SPR
SCHEMBL27339336 0.84 MEN1 (0.45) POLBMEN1KMT2AL3MBTL1SPR
SCHEMBL27352511 0.82 L3MBTL1 (0.43) POLBMEN1KMT2AL3MBTL1SPR
SCHEMBL7522157 0.81 PIM1 (0.54) NPC1MEN1KMT2AL3MBTL1SPR
SCHEMBL2140056 0.80 SPR (0.65) NPC1POLBL3MBTL1SPRHPGD
SCHEMBL7455826 0.80 PIM1 (0.52) MEN1KMT2AL3MBTL1SPRHPGD
SCHEMBL28326660 0.78 NAPRT (0.54) POLBMEN1KMT2AL3MBTL1HPGD
SCHEMBL9193063 0.78 SPR (0.67) NPC1POLBMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP claimed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A NPC1 1285/4885POLB 1698/4885MEN1 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.